VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CYH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CYHCommunity Health Systems, Inc.
$2.21$312M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCYHCash Flow

Community Health Systems, Inc. (CYH) Cash Flow Statement

27Y historyFree accessUpdated daily

Free cash flow margin ranged from -3.1% to 5.5% across the period, with operating cash flow of -$297.0M in 2026Q1 showing cash conversion is erratic rather than dependable.

Income StatementBalance SheetCash FlowRatios

CYH Cash Flow Statement

Annual statement

CYH Cash Flow Statement

Community Health Systems, Inc. (CYH) cash flow statement — 27-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99
Cash from Operations211M543M480M210M300M-131M2.18B385M274M773M1.14B921M1.61B1.09B1.28B1.26B1.19B1.08B1.06B687.74M350.25M411.05M325.75M243.7M285.5M154.39M22.98M-11.75M
Operating CF Margin %-4.35%3.8%1.68%2.46%-1.06%18.47%2.91%1.94%5.03%6.17%4.74%8.66%8.38%9.83%10.6%10.43%8.89%9.75%9.65%8.02%11%9.77%8.6%12.97%9.12%1.72%-1.09%
Operating CF Growth %-201.16%13.13%128.57%-30%329.01%-106.01%465.71%40.51%-64.55%-32.01%23.45%-42.97%48.34%-14.95%1.44%6.16%10.43%1.81%53.73%96.35%-14.79%26.19%33.67%-14.64%84.92%571.69%295.68%-
Net Income-516M676M-516M-133M46M230M511M-675M-788M-2.45B-1.71B194M149M141.2M266.11M260.22M279.98M241.58M206.66M59.9M171.48M190.14M158.22M131.47M99.98M44.74M9.57M-16.79M
Depreciation & Amortization437M426M486M505M534M540M558M608M700M861M1.1B1.17B1.18B782.67M725.56M652.67M609.84M566.21M499.08M332.58M188.77M164.56M158.38M143.77M118.22M119.67M97.62M81.65M
Stock-Based Compensation7M11M00000000000000000000013K26K44K00
Deferred Taxes32M-243M-116M35M165M170M-187M203M-3M-454M-116M103M107M69.28M53.41M107.03M97.37M34.27M159.87M-39.89M-25.23M9.89M41.9M61.57M38.17M25.28M17.21M-3.8M
Other Non-Cash Items-141M-330M635M193M34M305M-29M520M783M2.29B2.04B270M392M291.49M275.32M204.88M109.52M146.47M98.55M93.35M17.27M819K-106K2.31M7.7M3.81M-5.03M-570K
Working Capital Changes-228M3M-9M-390M-479M-1.38B1.32B-271M-418M525M-177M-818M-214M-195.93M-40.27M37.1M92.02M87.9M93.12M241.81M-2.04M45.64M-32.65M-95.43M21.4M-39.16M-96.46M-86.32M
Change in Receivables-89M99M-66M-193M22M-136M309M93M31M732M-96M-219M-306M-285.44M-204.15M-138.33M-27.05M58.39M-57.44M131.3M-71.14M-47.45M-31.81M-150.84M-19.1M-22.94M00
Change in Inventory77M0000000000000000000-4.54M-16.84M-13.55M-13.73M-12.57M2M-15.6M-17.6M
Change in Payables-116M-36M137M-50M-158M16M-67M-157M0000147M72.47M246.3M246.11M161.95M86.1M119.6M125.96M52.15M84.96M-23.29M34.72M26M-26.95M00
Cash from Investing1.03B847M-277M-22M-251M-543M191M-3M-273M1.07B-608M-1.04B-4.35B-991.27M-1.38B-1.2B-1.04B-867.18M-665.47M-7.5B-640.26M-327.27M-318.48M-620.77M-291.14M-265.11M-244.44M-155.54M
Capital Expenditures-333M-335M-360M-467M-415M-469M-440M-438M-527M-570M-867M-1.01B-853M-613.99M-768.79M-1.19B-667.38M-576.89M-692.23M-522.78M-260.87M-223.22M-194.09M-596.95M-103.97M-83.23M-63.01M-80.25M
CapEx % of Revenue1.51%2.68%2.85%3.74%3.4%3.79%3.73%3.32%3.72%3.71%4.7%5.2%4.58%4.72%5.9%10.01%5.86%4.76%6.39%7.33%5.98%5.97%5.82%21.06%4.73%4.91%4.71%7.43%
Acquisitions1.41B1.26B152M426M126M5M665M593M359M1.7B139M181M-2.95B-37.33M-316.42M184.55M-239.85M-170.24M217.21M-6.9B-379.39M-104.06M-124.39M00-150.94M-148.22M-59.7M
Investments----------------------------
Other Investing-15M-62M00121M00000000-339.94M00-137.08M-120.05M-190.45M-72.67M000-23.82M-187.16M-30.94M-33.22M-15.59M
Cash from Financing-1.21B-1.17B-204M-268M-438M-495M-909M-362M-368M-1.52B-1.69B-206M2.87B-111.86M361.03M-235.44M-189.79M-85.36M-304.03M6.9B226.46M-62.17M58.9M260.55M130.1M105.37M230.91M164.85M
Debt Issued (Net)-1.04B-1B-48M-123M-305M-369M-794M-322M-1.07B-1.52B-1.86B-158M2.88B-440.61M130.14M-92.65M-61.48M-58.26M-106.78M6.9B380.78M-26.84M357.06M275.16M137.34M-197.89M-284.25M165.41M
Equity Issued (Net)-2M-2M-1M-4M-8M-5M-1M-1M-1M-5M-6M-154M45M68.63M11.54M-66.88M-57.05M12.76M-88.38M8.21M-161.74M-31.53M-280.62M-10.44M2.54M308.97M515.16M-565K
Dividends Paid00000000000000-22.54M0000000-1.24M00000
Share Repurchases-2M-2M-1M-4M-8M-5M-1M-1M-1M-5M-6M-179M-20M-42.03M-9.31M-85.79M-113.96M0-90.19M0-176.32M-79.85M-290.52M-14.71M0-91K0-2.78M
Other Financing-171M-165M-155M-141M-125M-121M-114M-39M701M5M174M106M-48M260.12M241.88M-75.91M-71.27M-39.87M-108.87M-4.43M7.42M-3.8M-17.54M-4.16M-9.79M-5.71M00
Net Change in Cash32M223M-1M-80M-389M-1.17B1.46B20M-367M325M54M-325M136M-14.41M257.95M-169.3M-45.37M123.89M87.78M92.31M-63.54M21.61M66.17M-116.51M124.46M-5.35M9.46M-2.44M
Free Cash Flow-122M208M120M-257M-115M-600M1.74B-53M-253M203M1.49B-89M762M474.73M511.33M69.83M521.35M499.54M365.05M164.95M125.74M222.68M161.46M-353.25M181.52M71.16M-40.02M-92M
FCF Margin %-0.55%1.67%0.95%-2.06%-0.94%-4.85%14.74%-0.4%-1.79%1.32%8.08%-0.46%4.09%3.65%3.92%0.59%4.57%4.13%3.37%2.31%2.88%5.96%4.84%-12.46%8.25%4.2%-2.99%-8.52%
FCF Growth %-185.31%73.33%146.69%-123.48%80.83%-134.52%3379.25%79.05%-224.63%-86.37%1773.03%-111.68%60.51%-7.16%632.2%-86.61%4.37%36.84%121.3%31.19%-43.54%37.92%145.71%-294.6%155.11%277.8%56.5%-
FCF per Share-0.901.540.91-1.97-0.88-4.5914.91-0.47-2.241.8213.45-0.776.745.065.690.775.615.463.871.741.312.261.61-3.491.670.79-0.58-1.69
FCF Conversion (FCF/Net Income)0.24x1.07x-0.93x-1.58x6.52x-0.57x4.26x-0.65x-0.35x-0.31x-0.66x5.83x17.55x7.71x4.82x6.25x4.25x4.43x4.84x22.71x2.08x2.45x2.15x1.85x2.86x3.45x2.40x0.70x
Interest Paid-650M000000000000000000000000000
Taxes Paid-76M000000000000000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityWeak
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Volatile working capital drives cash swings

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Operating Cash Flow Diverges From Earnings

According to reported figures, CYH's operating cash flow to net income ratio swung from negative 9.23x to 2.42x across the ten quarters, with the 2026Q1 net loss of $610.0M paired with $297.0M of negative operating cash flow signaling that conversion is erratic rather than dependable.

The quarterly ratio is distorted by sign flips whenever net income is near zero or negative, which makes it an unreliable gauge of earnings quality on its own. Large working capital movements, including the $347.0M outflow in 2026Q1 and the $92.0M inflow in 2025Q4, appear to account for much of the gap between reported earnings and operating cash generation. Investors should monitor whether these swings reverse, since the pattern suggests timing effects rather than a durable conversion trend.

Free Cash Flow Thin and Inconsistent

Based on reported figures, CYH's free cash flow margin ranged from negative 3.1% to 5.5% over the period, with four of ten quarters negative or near zero, indicating limited and unstable cash generation against a roughly $3.1B quarterly revenue base.

Free cash flow was positive in most quarters but rarely exceeded modest levels, and the 2026Q1 burn of $373.0M is the dominant negative observation in the series. The 2025Q4 margin of 5.5% appears to be driven by working capital inflows rather than a sustained improvement in operations. Trajectory assessment therefore depends heavily on whether working capital normalizes, which warrants further investigation.

Capital Spending Tracks Depreciation Closely

As reported in financial statements, CYH's capital expenditure ran between roughly 0.6% and 3.3% of revenue, with quarterly outlays of $65.0M to $109.0M set against depreciation of $105.0M to $129.0M in most periods.

Capex broadly tracks depreciation, which suggests the company is spending largely to maintain its existing asset base rather than to expand capacity. The reported split between maintenance and growth capex is not provided, so this inference cannot be confirmed from the data. The low 0.6% capex intensity in 2026Q1 may reflect timing rather than a deliberate reduction, and investors should watch whether spending resumes at prior levels.

Limited Cash Returned to Shareholders

Per the supplied cash flow data, CYH recorded no dividends across the ten quarters and buybacks of only $1.0M to $2.0M in the periods where they appeared, while acquisition-related cash flows ranged from negative $24.0M to $1.1B.

The absence of dividends and minimal buyback activity suggest that available cash has been directed toward balance sheet or operational needs rather than shareholder returns. The large acquisition-related inflows are difficult to interpret without disclosure of the underlying transactions, and that detail is unavailable here. This pattern warrants further investigation before firm conclusions about capital allocation priorities are drawn.

Reported Cash Strength May Be Flattered

Based on the supplied figures, CYH's positive quarterly free cash flow in most periods may overstate underlying generation, since the 2025Q4 and 2026Q2 inflows coincided with working capital releases of $92.0M and a $62.0M acquisition-related inflow respectively.

A bull reading would emphasize the $67.0M free cash flow in 2026Q3 and the $172.0M in 2025Q4 as evidence of recovering cash generation. However, several of the strongest quarters rely on working capital movements or acquisition-related cash flows that do not recur predictably, which may flatter the trend. Stock-based compensation is reported as zero throughout, so no adjustment for equity-based costs is needed from this data, though the reliability of the underlying classifications remains unverified.

CYH — Frequently Asked Questions

Quick answers to the most common questions about buying CYH stock.

How much cash does Community Health Systems, Inc. (CYH) generate from operations?

Community Health Systems, Inc. (CYH) generated $543.0M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Community Health Systems, Inc.'s free cash flow?

Community Health Systems, Inc. (CYH) generated $208.0M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Community Health Systems, Inc.'s capital expenditure (CapEx)?

Community Health Systems, Inc. (CYH) spent $335.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Community Health Systems, Inc. distribute cash to shareholders?

In 2025, Community Health Systems, Inc. (CYH) spent $2.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.